Anti-platelet + Pembro for H&N Tumors

NCT03245489 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

DRUG: Pembrolizumab
DRUG: Clopidogrel
DRUG: acetylsalicylic acid

Sponsor

Medical University of South Carolina